Related Experiment Video
Updated: Feb 6, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
DNA methylation patterns of the S100A14, POU2F3 and SFN genes in equine sarcoid tissues
E Semik-Gurgul1, T Ząbek1, A Fornal1
1National Research Institute of Animal Production, Department of Animal Genomics and Molecular Biology, Krakowska 1, 32-083 Balice, Poland.
Abstract:
Genetic and epigenetic alterations in the equine sarcoid, a locally invasive skin tumour of equids, are still poorly characterized. Numerous studies have provided reliable evidence for the relationship between the development of cancer and the loss of function of a number of tumour suppressor genes. In the present study, we assessed methylation levels in the promoter region of SFN, S100A14 and POU2F3 genes in sarcoid samples to clarify whether DNA methylation may be associated with previously identified changes in the expression level of these genes during the course of tumour progression. Using bisulfite sequencing and clone sequencing, we detected that lesional samples had a significantly higher rate of DNA methylation in the analyzed S100A14A region than the corresponding normal skin tissue. A frequent methylation of the SFN and POU2F3 promoter sequences were observed in both the tumour samples and the control skin tissues. Further studies are needed to evaluate the role of aberrant methylation in sarcoid progression and to understand the mechanisms involved in reduced expression of SFN, S100A14 and POU2F3 genes in the lesional tissues.
Insights
Equine sarcoid tumors show increased DNA methylation in the S100A14A gene promoter region. Further research is needed to understand the role of aberrant methylation in equine sarcoid progression.
Area of Science:
- Veterinary Oncology
- Epigenetics
- Equine Dermatology
Background:
- Equine sarcoids are locally invasive skin tumors in horses.
- Genetic and epigenetic alterations, particularly in tumor suppressor genes, are implicated in cancer development.
- The role of DNA methylation in equine sarcoid progression is not well understood.
Purpose of the Study:
- To investigate DNA methylation levels in the promoter regions of SFN, S100A14, and POU2F3 genes in equine sarcoid samples.
- To determine if DNA methylation correlates with altered gene expression during tumor progression.
Main Methods:
- Bisulfite sequencing and clone sequencing were employed.
- Methylation levels in promoter regions of SFN, S100A14, and POU2F3 were analyzed.
- Lesional sarcoid samples were compared with corresponding normal skin tissue.
Main Results:
- Significantly higher DNA methylation rates were observed in the S100A14A promoter region of lesional sarcoid samples compared to normal skin.
- Frequent methylation of SFN and POU2F3 promoter sequences was detected in both tumor and control tissues.
- Aberrant methylation patterns may contribute to altered gene expression in equine sarcoids.
Conclusions:
- DNA methylation in the S100A14A promoter is associated with equine sarcoid development.
- Further investigation is required to elucidate the precise role of aberrant methylation in sarcoid progression.
- Understanding these epigenetic mechanisms could lead to novel therapeutic strategies for equine sarcoids.
Related Concept Videos
Fixed Action Patterns
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Recombinant DNA
Gene Conversion
Complementary DNA
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...

